Kyverna Therapeutics Ownership | Who Owns Kyverna Therapeutics?
Kyverna Therapeutics Ownership Summary
Kyverna Therapeutics is owned by 53.67% institutional investors, 12.03% insiders, and 34.30% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 7.79% of KYTX shares.
KYTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kyverna Therapeutics | 53.67% | 12.03% | 34.30% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bain capital life sciences investors | 3.37M | 7.79% | $10.34M |
| Insight group | 989.05K | 2.29% | $3.04M |
| Mbb public markets i | 614.48K | 1.42% | $1.89M |
| Blackrock funding, inc. /de | 533.47K | 1.23% | $1.64M |
| Superstring capital management lp | 142.54K | 0.33% | $437.60K |
| Marshall wace, llp | 62.06K | 0.14% | $190.51K |
| Point72 asset management | 55.52K | 0.13% | $170.45K |
| Y-intercept (hong kong) | 42.02K | 0.10% | $129.02K |
| Prelude capital management | 36.25K | 0.08% | $111.28K |
| Xtx topco | 34.94K | 0.08% | $107.26K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 3.37M | 1.29% | $10.34M |
| Caxton | 22.98K | 0.72% | $70.55K |
| Superstring capital management lp | 142.54K | 0.52% | $437.60K |
| Mbb public markets i | 614.48K | 0.18% | $1.89M |
| Insight group | 989.05K | 0.13% | $3.04M |
| Phoenix wealth advisors | 10.50K | 0.01% | $32.23K |
| Prelude capital management | 36.25K | 0.01% | $111.28K |
| Point72 asia (singapore) pte. | 12.04K | 0.01% | $36.96K |
| Xtx topco | 34.94K | 0.00% | $107.26K |
| Y-intercept (hong kong) | 42.02K | 0.00% | $129.02K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 55.52K | 0.00% | 55.52K |
| Y-intercept (hong kong) | 42.02K | 0.00% | 42.02K |
| Marshall wace, llp | 62.06K | 0.00% | 37.50K |
| Xtx topco | 34.94K | 0.00% | 34.94K |
| Hrt financial lp | 20.17K | 0.00% | 20.17K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Novo | - | - | -1.85M |
| Blackrock funding, inc. /de | 533.47K | - | -1.14M |
| Integral health asset management | - | - | -350.00K |
| Ameriprise financial | - | - | -190.38K |
| Rock springs capital management lp | - | - | -178.96K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 55.52K | 0.00% | 55.52K | $170.45K |
| Y-intercept (hong kong) | 42.02K | 0.00% | 42.02K | $129.02K |
| Hrt financial lp | 20.17K | 0.00% | 20.17K | $61.00K |
| Ethic | 17.04K | 0.00% | 17.04K | $55.88K |
| Qube research | 14.05K | - | 14.05K | $43.14K |
Sold Out
| Holder | Change |
|---|---|
| Rothschild investment | -50.00 |
| Jones financial companies lllp | -81.00 |
| Sterling capital management | -186.00 |
| Physician wealth advisors | -420.00 |
| Amalgamated bank | -582.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 79 | -10.23% | 23,198,522 | -10.03% | 53 | 1.51% | 44 | 4.76% | 24 | -4.00% |
| Mar 31, 2025 | 88 | -1.12% | 25,809,724 | -9.40% | 59 | 1.37% | 41 | -26.79% | 25 | 92.31% |
| Dec 31, 2024 | 90 | -4.26% | 28,867,980 | 2.72% | 66 | 1.58% | 57 | 11.76% | 13 | -38.10% |
| Sep 30, 2024 | 94 | 4.44% | 28,104,372 | -12.02% | 65 | 1.19% | 51 | -19.05% | 21 | 90.91% |
| Jun 30, 2024 | 90 | -2.17% | 31,942,911 | 4.22% | 74 | 0.44% | 63 | -29.21% | 11 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 12, 2024 | GILEAD SCIENCES, INC. | - | Buy | $20.02M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q1 | 1 | - |
KYTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools